MANCARDI, GIOVANNI LUIGI
 Distribuzione geografica
Continente #
EU - Europa 55.108
NA - Nord America 6.614
AS - Asia 5.087
Continente sconosciuto - Info sul continente non disponibili 576
SA - Sud America 566
AF - Africa 100
OC - Oceania 7
Totale 68.058
Nazione #
IT - Italia 54.265
US - Stati Uniti d'America 6.158
SG - Singapore 2.226
CN - Cina 1.262
VN - Vietnam 764
FR - Francia 407
BR - Brasile 327
BD - Bangladesh 289
CA - Canada 205
HK - Hong Kong 169
DE - Germania 100
AR - Argentina 89
FI - Finlandia 59
GB - Regno Unito 57
JP - Giappone 54
MX - Messico 53
CO - Colombia 45
IN - India 45
ID - Indonesia 44
JM - Giamaica 42
CH - Svizzera 39
IQ - Iraq 39
EC - Ecuador 37
CR - Costa Rica 31
NL - Olanda 27
ES - Italia 24
HN - Honduras 22
VE - Venezuela 22
TH - Thailandia 19
ZA - Sudafrica 19
CL - Cile 18
TR - Turchia 18
TT - Trinidad e Tobago 18
GT - Guatemala 17
SA - Arabia Saudita 17
UA - Ucraina 17
NI - Nicaragua 14
IE - Irlanda 13
PH - Filippine 13
PK - Pakistan 13
RU - Federazione Russa 13
PR - Porto Rico 12
SV - El Salvador 12
KE - Kenya 11
MA - Marocco 11
MY - Malesia 11
TN - Tunisia 11
TW - Taiwan 11
DZ - Algeria 10
JO - Giordania 10
PL - Polonia 9
UZ - Uzbekistan 9
BB - Barbados 8
EG - Egitto 8
HR - Croazia 8
LB - Libano 8
PY - Paraguay 8
SC - Seychelles 8
SE - Svezia 8
BO - Bolivia 7
IL - Israele 7
KR - Corea 7
LT - Lituania 7
NP - Nepal 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
BE - Belgio 6
PS - Palestinian Territory 6
UY - Uruguay 6
AT - Austria 5
AU - Australia 5
EE - Estonia 5
KG - Kirghizistan 5
PA - Panama 5
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
KZ - Kazakistan 4
MN - Mongolia 4
RS - Serbia 4
SN - Senegal 4
AL - Albania 3
BS - Bahamas 3
BY - Bielorussia 3
BZ - Belize 3
GH - Ghana 3
RO - Romania 3
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
HT - Haiti 2
HU - Ungheria 2
LK - Sri Lanka 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
SI - Slovenia 2
Totale 67.448
Città #
Genova 35.457
Genoa 11.101
Rapallo 4.076
Vado Ligure 2.943
San Jose 1.332
Singapore 1.067
Ashburn 887
Lauterbourg 377
Council Bluffs 333
Ho Chi Minh City 223
Beijing 203
New York 184
Hanoi 175
Hong Kong 154
Santa Clara 142
Carrboro 121
Los Angeles 93
Phoenix 87
Rome 85
Bordighera 80
Frankfurt am Main 78
Milan 74
Dallas 64
Chicago 61
Helsinki 59
São Paulo 56
Atlanta 46
Tokyo 44
Buffalo 37
Da Nang 35
Haiphong 35
Zurich 35
Mexico City 34
Naples 33
Toronto 31
Washington 31
Brooklyn 27
Montreal 27
Orem 27
San José 26
Tianjin 26
Kingston 25
Houston 24
Newark 23
San Francisco 23
Detroit 22
North Bergen 21
Philadelphia 20
Charlotte 19
Amsterdam 17
Queens 17
Turin 17
Las Vegas 16
Biên Hòa 15
Guatemala City 15
Shanghai 15
Florence 14
Calgary 13
Johannesburg 13
Managua 13
Baghdad 12
Bogotá 12
Miami 12
Palermo 12
Brasília 11
Catania 11
Cincinnati 11
Denver 11
Des Moines 11
Dublin 11
Guayaquil 11
Princeton 11
San Antonio 11
The Bronx 11
Bar Harbor 10
Bologna 10
Caracas 10
Columbia 10
Madrid 10
Nuremberg 10
Padua 10
Santiago 10
Can Tho 9
Columbus 9
Hải Dương 9
Louisville 9
Manchester 9
Nairobi 9
Paris 9
San Salvador 9
Seattle 9
Walled Lake 9
Warsaw 9
Wilmington 9
Amman 8
Bari 8
Buenos Aires 8
Cali 8
Chennai 8
City of London 8
Totale 60.742
Nome #
An updated Italian normative dataset for the Stroop color word test (SCWT) 290
Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS 275
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. 259
17p11.2 duplication is a common finding in sporadic cases of charcot-marie-tooth type 1 255
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 251
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy 247
Dysimmune mononeuropathies: A diagnosis not to be missed 246
A normative study of the Italian printed word version of the free and cued selective reminding test 245
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. 240
An engineered glove for investigating the neural correlates of finger movements using functional magnetic resonance imaging 238
Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis 236
Neural correlates of ankle movements during different motor tasks: A feasibility study 234
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 230
Clinical epidemiology of ALS in Liguria, Italy. 229
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 228
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 228
An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. 228
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 228
Acute axonal form of Guillain-Barre syndrome in a multiple sclerosis patient: chance association or linked disorders? 223
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report. 221
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 219
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption 219
Different MRI patterns in MS worsening after stopping fingolimod 219
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 218
Neural correlates of lower limbs proprioception: An fMRI study of foot position matching 217
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 215
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. 213
Basal ganglia are active during motor performance recovery after a demanding motor task. 213
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. 212
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 211
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 211
Fast course ALS presenting with vocal cord paralysis: clinical features, bioinformatic and modelling analysis of the novel SOD1 Gly147Ser mutation. 210
A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis 210
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 210
Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine 209
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 209
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 208
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 208
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 206
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 204
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 204
Evidence for aerobic ATP synthesis in isolated myelin vesicles 203
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 202
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 202
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 202
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. 201
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 200
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. 199
Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017 199
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 198
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 197
The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. 197
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 196
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 196
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 195
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 194
Delirium in the acute phase after stroke: comparison between methods of detection 194
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. 194
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 193
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 193
National Institutes of Health Stroke Scale in patients with primary intracerebral hemorrhage 193
A patient with multiple sclerosis and Down's syndrome with a rare paroxysmal symptom at onset. 192
Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks 191
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. 191
Impairment in explicit visuomotor sequence learning is related to loss of microstructural integrity of the corpus callosum in multiple sclerosis patients with minimal disability. 191
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 189
Direct immunofluorescence in sural nerve biopsies. 188
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. 188
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 187
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 187
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. 187
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 187
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 187
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 186
Screening, diagnosis, and management of obstructive sleep apnea in dangerous-goods truck drivers: to be aware or not? 186
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis 186
Early electophysiological changes in transgenic rat model of charcot-marie-tooth. 185
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach 185
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. 185
Teriflunomide treatment reduces B cells in patients with MS. 185
Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis 185
[Hereditary sensory motor neuropathy: degenerative disease or a disease with an immune-mediated pathogenesis?]. 184
OXCARBAZEPINE FOR TREATING PAROXYSMAL PAINFUL SYMPTOMS IN MULTIPLE SCLEROSIS: A PILOT STUDY. 183
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. 183
'Apraxia' of eye opening in idiopathic Parkinson's disease. 183
GFAP expression of human Schwann cells in tissue culture. 183
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 183
Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter? 183
Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients. 182
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 182
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 182
A prospective study of acute idiopathic neuropathy II antecedent events. 181
CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS 181
Neurological research in Italy in 2003 and 2004. 180
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis. 180
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 180
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 179
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis. 178
Cingulum bundle alterations underlie subjective fatigue in multiple sclerosis 178
Three years of experience: the Italian registry and safety data update 178
Totale 20.415
Categoria #
all - tutte 210.369
article - articoli 191.829
book - libri 963
conference - conferenze 16.070
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.507
Totale 420.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.273 0 0 0 695 170 292 287 1.250 217 494 152 716
2022/20234.881 491 396 58 467 803 858 20 370 854 27 467 70
2023/20242.539 154 340 64 283 190 521 201 152 131 35 122 346
2024/20257.294 248 564 249 465 989 778 631 1.134 324 335 627 950
2025/202612.726 1.593 388 745 1.100 1.688 1.292 2.079 582 799 1.171 565 724
2026/20274.625 1.357 370 1.053 1.845 0 0 0 0 0 0 0 0
Totale 68.058